Nippon Shinyaku (4516) Fundamentals 2026 — P/E 9.1x, Revenue Analysis | SniperIQ
Nippon Shinyaku (4516) is a JP-listed Healthcare company in Drug Manufacturers - Specialty & Generic with a market capitalization of ¥270.9B, trading at ¥4019.00 on the JPX. This SniperIQ fundamentals page covers Nippon Shinyaku's valuation (P/E 9.1x, P/B 0.9x), profitability (net margin 17.4%), revenue (¥170.8B in FY2026), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is Nippon Shinyaku's market cap?
Nippon Shinyaku (4516) has a market capitalization of approximately ¥270.9B, trading at ¥4019.00 on the JPX. Market cap moves with the live share price.
What is Nippon Shinyaku's P/E ratio?
Nippon Shinyaku's trailing twelve-month P/E ratio is 9.1x, with a price-to-book (P/B) of 0.9x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
How profitable is Nippon Shinyaku?
Nippon Shinyaku runs a net profit margin of 17.4%, a gross margin of 66.4%, and an operating margin of 19.3%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Nippon Shinyaku generate?
Nippon Shinyaku reported revenue of ¥170.8B for fiscal year 2026, with net income of ¥29.7B and earnings per share (EPS) of 441.25. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does Nippon Shinyaku pay a dividend?
Nippon Shinyaku offers a trailing dividend yield of about 3.1%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.
Is Nippon Shinyaku financially healthy?
Nippon Shinyaku carries a debt-to-equity ratio of 0.01x and a current ratio of 4.35x, with a market beta of -0.31. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Nippon Shinyaku a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Nippon Shinyaku (4516) the key facts are: market cap ¥270.9B, P/E 9.1x, revenue ¥170.8B, 52-week range 3067-6529. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.
Track Nippon Shinyaku's full fundamentals live
Get Nippon Shinyaku's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.